Literature DB >> 16216754

Cibenzoline induced Brugada ECG pattern.

Andrea Sarkozy1, Axel Caenepeel, Peter Geelen, Peter Peytchev, Marc de Zutter, Pedro Brugada.   

Abstract

We report a case of a 61-year-old female patient who presented with palpitations. The baseline electrocardiogram showed incomplete right bundle branch block with saddle back pattern of the ST segment in one precordial lead, but without any significant ST elevation. She was treated with oral cibenzoline. The subsequent ECG showed a coved Brugada ECG (type I) pattern, which resolved following the discontinuation of cibenzoline. An ajmaline test reproduced the coved type Brugada ECG pattern. Our case is the first report of oral cibenzoline therapy unmasking the diagnostic coved Brugada ECG pattern in a patient with a baseline normal ECG. Cibenzoline, a class I sodium channel blocker antiarrhythmic drug, should probably be avoided in the treatment of patients with Brugada syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216754     DOI: 10.1016/j.eupc.2005.06.013

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  3 in total

Review 1.  Drug-induced spatial dispersion of repolarization.

Authors:  Charles Antzelevitch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

Review 2.  Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2006-10       Impact factor: 1.976

Review 3.  Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org).

Authors:  Pieter G Postema; Christian Wolpert; Ahmad S Amin; Vincent Probst; Martin Borggrefe; Dan M Roden; Silvia G Priori; Hanno L Tan; Masayasu Hiraoka; Josep Brugada; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2009-07-08       Impact factor: 6.343

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.